Trial Profile
A Randomized Controlled Study of Postoperative Adjuvant Therapy of UFT Compared With CMF in High-Risk Women With Axillary Node-Negative Breast Cancer (NSAS-BC).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Jul 2021
Price :
$35
*
At a glance
- Drugs Tegafur/uracil (Primary) ; Cyclophosphamide; Fluorouracil; Methotrexate
- Indications Breast cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Taiho Pharmaceutical
- 09 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Feb 2009 Status changed from completed to active, no longer recruiting.
- 09 Feb 2009 Results were published in the Journal of Clinical Oncology.